van der Kuip, Heiko <br/><br/>
Mechanisms of clinical resistance to small molecule tyrosine kinase inhibitors targeting oncogenic tyrosine kinases.  [electronic resource] 

 -  American journal of pharmacogenomics : genomics-related research in drug development and clinical practice  2005 
 - 101-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1175-2203 
<br/><br/><label>Standard No.: </label>10.2165/00129785-200505020-00003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzamides<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Imatinib Mesylate<br/>Mutation<br/>Neoplasms--drug therapy<br/>Piperazines--therapeutic use<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrimidines--therapeutic use